Key facts
- This page summarizes Heather Rees's Form 4 filing for ATOSSA THERAPEUTICS, INC. (ATOS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 01 Jul 2024, 16:00.
Heather Rees - 27 Jun 2024 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)
- Reporting relationship
- SVP, Finance and Accounting
- Issuer ticker
- ATOS
- Reported as of
- 27 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Jul 2024, 16:00:09 UTC
- Prior SEC filing
- 16 Oct 2023
- Next SEC filing
- 16 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Heather Rees
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Heather Rees filed Form 4 for ATOSSA THERAPEUTICS, INC. (ATOS) on 01 Jul 2024.
Change
- Previous filing in this sequence was filed on 16 Oct 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATOS
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +577,700
- Change %
- Price
- $0.000000
- Shares after
- 577,700
- Date
- 27 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 577,700
- Exercise price
- $1.05
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The options shall vest on a quarterly basis over 24 months following June 27, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024, with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024.